Dexin Statistics
Total Valuation
Dexin has a market cap or net worth of TWD 1.40 billion. The enterprise value is 1.25 billion.
| Market Cap | 1.40B |
| Enterprise Value | 1.25B |
Important Dates
The next estimated earnings date is Tuesday, March 17, 2026.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Dexin has 46.07 million shares outstanding. The number of shares has increased by 3.13% in one year.
| Current Share Class | 46.07M |
| Shares Outstanding | 46.07M |
| Shares Change (YoY) | +3.13% |
| Shares Change (QoQ) | +12.37% |
| Owned by Insiders (%) | 10.51% |
| Owned by Institutions (%) | n/a |
| Float | 25.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.59 |
| PB Ratio | 3.83 |
| P/TBV Ratio | 3.97 |
| P/FCF Ratio | 44.08 |
| P/OCF Ratio | 36.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 111.44, with an EV/FCF ratio of 39.19.
| EV / Earnings | -51.99 |
| EV / Sales | 2.30 |
| EV / EBITDA | 111.44 |
| EV / EBIT | n/a |
| EV / FCF | 39.19 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.39 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 5.03 |
| Debt / FCF | 1.78 |
| Interest Coverage | -5.23 |
Financial Efficiency
Return on equity (ROE) is -7.20% and return on invested capital (ROIC) is -7.73%.
| Return on Equity (ROE) | -7.20% |
| Return on Assets (ROA) | -1.95% |
| Return on Invested Capital (ROIC) | -7.73% |
| Return on Capital Employed (ROCE) | -4.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.95 |
| Inventory Turnover | 5.56 |
Taxes
In the past 12 months, Dexin has paid 7.06 million in taxes.
| Income Tax | 7.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +101.33% in the last 52 weeks. The beta is 0.15, so Dexin's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +101.33% |
| 50-Day Moving Average | 28.02 |
| 200-Day Moving Average | 20.58 |
| Relative Strength Index (RSI) | 54.46 |
| Average Volume (20 Days) | 582,533 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexin had revenue of TWD 540.58 million and -23.95 million in losses. Loss per share was -0.58.
| Revenue | 540.58M |
| Gross Profit | 118.80M |
| Operating Income | -17.70M |
| Pretax Income | -16.89M |
| Net Income | -23.95M |
| EBITDA | -778,000 |
| EBIT | -17.70M |
| Loss Per Share | -0.58 |
Balance Sheet
The company has 211.91 million in cash and 56.55 million in debt, with a net cash position of 155.36 million or 3.37 per share.
| Cash & Cash Equivalents | 211.91M |
| Total Debt | 56.55M |
| Net Cash | 155.36M |
| Net Cash Per Share | 3.37 |
| Equity (Book Value) | 366.06M |
| Book Value Per Share | 7.95 |
| Working Capital | 244.77M |
Cash Flow
In the last 12 months, operating cash flow was 38.55 million and capital expenditures -6.77 million, giving a free cash flow of 31.78 million.
| Operating Cash Flow | 38.55M |
| Capital Expenditures | -6.77M |
| Free Cash Flow | 31.78M |
| FCF Per Share | 0.69 |
Margins
Gross margin is 21.98%, with operating and profit margins of -3.27% and -4.43%.
| Gross Margin | 21.98% |
| Operating Margin | -3.27% |
| Pretax Margin | -3.12% |
| Profit Margin | -4.43% |
| EBITDA Margin | -0.14% |
| EBIT Margin | -3.27% |
| FCF Margin | 5.88% |
Dividends & Yields
Dexin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.13% |
| Shareholder Yield | -3.13% |
| Earnings Yield | -1.71% |
| FCF Yield | 2.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 30, 2022. It was a forward split with a ratio of 1.04.
| Last Split Date | Aug 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.04 |
Scores
Dexin has an Altman Z-Score of 2.85 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 5 |